Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli

European Journal of Immunology

Volumn 37, Issue 10, 2007, Pages 2923-2936

  Donahue, Amber C ^a   Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B lymphocyte; Cell activation; Cell proliferation; Lipopolysaccharide; Signal transduction

Indexed keywords

B LYMPHOCYTE ANTIGEN RECEPTOR; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL SELECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; B-LYMPHOCYTE SUBSETS; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN KINASES; RECEPTORS, ANTIGEN, B-CELL; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; SPLEEN;

EID: 35348852627     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737281     Document Type: Article

References (69)

1. Lopes-Carvalho, T. and Kearney, J. F., Development and selection of marginal zone B cells. Immunol. Rev. 2004. 197: 192-205.
2. Srivastava, B., Lindsley, R. C., Nikbakht, N. and Allman, D., Models for peripheral B cell development and homeostasis. Semin. Immunol. 2005. 17: 175-182.
3. Lopes-Carvalho, T., Foote, J. and Kearney, J. F., Marginal zone B cells in lymphocyte activation and regulation. Curr. Opin. Immunol. 2005. 17: 244-250.
4. Benschop, R. J., Brandl, E., Chan, A. C. and Cambier, J. C., Unique signaling properties of B cell antigen receptor in mature and immature B cells: Implications for tolerance and activation. J. Immunol. 2001. 167: 4172-4179.
5. Benschop, R. J., Melamed, D., Nemazee, D. and Cambier, J. C., Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells. J. Exp. Med. 1999. 190: 749-756.
6. Li, X., Martin, F., Oliver, A. M., Kearney, J. F. and Carter, R. H., Antigen receptor proximal signaling in splenic B-2 cell subsets. J. Immunol. 2001. 166: 3122-3129.
7. Wang, Y., Zhang, P., Li, W., Hou, L., Wang, J., Liang, Y. and Han, H., Mouse follicular and marginal zone B cells show differential expression of Dnmt3a and sensitivity to 5′-azacytidine. Immunol. Lett. 2006. 105: 174-179.
8. Zhang, P., Li, W., Wang, Y., Hou, L., Xing, Y., Qin, H., Wang, J. et al., Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis. Mol. Immunol. 2007. 44: 332-337.
9. Donahue, A. C. and Fruman, D. A., PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin. Cell Dev. Biol. 2004. 15: 183-197.
10. Donahue, A. C. and Fruman, D. A., Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J. Immunol. 2003. 170: 5851-5860.
11. Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L., Yu, J. Y., Alt, F. W. and Cantley, L. C., Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 1999. 283: 393-397.
12. Bilancio, A., Okkenhaug, K., Camps, M., Emery, J. L., Ruckle, T., Rommel, C. and Vanhaesebroeck, B., Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: Comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 2006. 107: 642-650.
13. Clayton, E., Bardi, G., Bell, S. E., Chantry, D., Downes, C. P., Gray, A., Humphries, L. A. et al., A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 2002. 196: 753-763.
14. Donahue, A. C., Hess, K. L., Ng, K. L. and Fruman, D. A., Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha. Int. Immunol. 2004. 16: 1789-1798.
15. Hess, K. L., Donahue, A. C., Ng, K. L., Moore, T. I., Oak, J. and Fruman, D. A., Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses. Eur. J. Immunol. 2004. 34: 2968-2976.
16. Jou, S. T., Carpino, N., Takahashi, Y., Piekorz, R., Chao, J. R., Carpino, N., Wang, D. and Ihle, J. N., Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol. Cell. Biol. 2002. 22: 8580-8591.
17. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W. et al., Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002. 297: 1031-1034.
18. Suzuki, H., Matsuda, S., Terauchi, Y., Fujiwara, M., Ohteki, T., Asano, T., Behrens, T. W. et al., PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 2003. 4: 280-286.
19. Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T. and Koyasu, S., Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999. 283: 390-392.
20. Piatelli, M. J., Wardle, C., Blois, J., Doughty, C., Schram, B. R., Rothstein, T. L. and Chiles, T. C., Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. J. Immunol. 2004. 172: 2753-2762.
21. Aagaard-Tillery, K. M. and Jelinek, D. F., Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell. Immunol. 1994. 156: 493-507.
22. Wicker, L. S., Boltz, R. C., Jr., Matt, V., Nichols, E. A., Peterson, L. B. and Sigal, N. H., Suppression of B cell activation by cyclosporine A, FK506 and rapamycin. Eur. J. Immunol. 1990. 20: 2277-2283.
23. Richardson, C. J., Schalm, S. S. and Blenis, J., PI3-kinase and TOR: PIKTORing cell growth. Semin. Cell Dev. Biol. 2004. 15: 147-159.
24. Wullschleger, S., Loewith, R. and Hall, M. N., TOR signaling in growth and metabolism. Cell 2006. 124: 471-484.
25. Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N. and Avruch, J., 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 1998. 8: 69-81.
26. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. and Cantley, L. C., Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 2002. 10: 151-162.
27. Wlodarski, P., Kasprzycka, M., Liu, X., Marzec, M., Robertson, E. S., Slupianek, A. and Wasik, M. A., Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res. 2005. 65: 7800-7808.
28. Hebeis, B. J., Vigorito, E. and Turner, M., The p110delta subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells. Biochem. Soc. Trans. 2004. 32: 789-791.
29. Lyubchenko, T., dal Porto, J., Cambier, J. C. and Holers, V. M., Coligation of the B cell receptor with complement receptor type 2 (CR2/ CD21) using its natural ligand C3dg: Activation without engagement of an inhibitory signaling pathway. J. Immunol. 2005. 174: 3264-3272.
30. Allman, D., Lindsley, R. C., Demuth, W., Rudd, K., Shinton, S. A. and Hardy, R. R., Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 2001. 167: 6834-6840.
31. Loder, F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C. and Carsetti, R., B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999. 190: 75-89.
32. Srivastava, B., Quinn, W. J., 3rd, Hazard, K., Erikson, J. and Allman, D., Characterization of marginal zone B cell precursors. J. Exp. Med. 2005. 202: 1225-1234.
33. Su, T. T. and Rawlings, D. J., Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 2002. 168: 2101-2110.
34. Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T. and Ravichandran, K. S., The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 1998. 273: 33922-33928.
35. Jacob, A., Cooney, D., Pradhan, M. and Coggeshall, K. M., Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 2002. 277: 23420-23426.
36. Krutzik, P. O., Clutter, M. R. and Nolan, G. P., Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J. Immunol. 2005. 175: 2357-2365.
37. Krutzik, P. O., Hale, M. B. and Nolan, G. P., Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J. Immunol. 2005. 175: 2366-2373.
38. Perez, O. D. and Nolan, G. P., Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 2002. 20: 155-162.
39. Perez, O. D. and Nolan, G. P., Phospho-proteomic immune analysis by flow cytometry: From mechanism to translational medicine at the single-cell level. Immunol. Rev. 2006. 210: 208-228.
40. Irish, J. M., Czerwinski, D. K., Nolan, G. P. and Levy, R., Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J. Immunol. 2006. 177: 1581-1589.
41. Donahue, A. C. and Fruman, D. A., Measuring phosphorylated Akt and other phosphoinositide-3-kinase-regulated phosphoproteins in primary lymphocytes. Methods Enzymol. 2007. 434: 131-154.
42. Anzelon, A. N., Wu, H. and Rickert, R. C., Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 2003. 4: 287-294.
43. Perez, O. D., Kinoshita, S., Hitoshi, Y., Payan, D. G., Kitamura, T., Nolan, G. P. and Lorens, J. B., Activation of the PKB/AKT pathway by ICAM-2. Immunity 2002. 16: 51-65.
44. Kam, Y. and Exton, J. H., Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid. FASEB J. 2004. 18: 311-319.
45. Dann, S. G. and Thomas, G., The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett. 2006. 580: 2821-2829.
46. Bone, H. and Williams, N. A., Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells. Int. Immunol. 2001. 13: 807-816.
47. Doyle, S., Vaidya, S., O'Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G. et al., IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002. 17: 251-263.
48. Manning, B. D., Balancing Akt with S6K: Implications for both metabolic diseases and tumorigenesis. J. Cell Biol. 2004. 167: 399-403.
49. Prabhu, S., Saadat, D., Zhang, M., Halbur, L., Fruehauf, J. P. and Ong, S. T., A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation. Oncogene 2007. 26: 1188-1200.
50. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999. 162: 7198-7207.
51. Hebeis, B., Vigorito, E., Kovesdi, D. and Turner, M., Vav proteins are required for B-lymphocyte responses to LPS. Blood 2005. 106: 635-640.
52. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H. and Kearney, J. F., Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 1997. 27: 2366-2374.
53. Omori, S. A., Cato, M. H., Anzelon-Mills, A., Puri, K. D., Shapiro-Shelef, M., Calame, K. and Rickert, R. C., Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 2006. 25: 545-557.
54. Aagaard-Tillery, K. M. and Jelinek, D. F., Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. J. Immunol. 1996. 156: 4543-4554.
55. Kumararatne, D. S., Bazin, H. and MacLennan, I. C., Marginal zones: The major B cell compartment of rat spleens. Eur. J. Immunol. 1981. 11: 858-864.
56. Byfield, M. P., Murray, J. T. and Backer, J. M., hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem. 2005. 280: 33076-33082.
57. Nobukuni, T., Joaquin, M., Roccio, M., Dann, S. G., Kim, S. Y., Gulati, P., Byfield, M. P. et al., Amino acids mediate mTOR/ raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc. Natl. Acad. Sci. USA 2005. 102: 14238-14243.
58. Avila-Flores, A., Santos, T., Rincon, E. and Merida, I., Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid. J. Biol. Chem. 2005. 280: 10091-10099.
59. Chen, J. and Fang, Y., A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. Biochem. Pharmacol. 2002. 64: 1071-1077.
60. Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. and Chen, J., Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001. 294: 1942-1945.
61. Tang, W., Yuan, J., Chen, X., Gu, X., Luo, K., Li, J., Wan, B. et al., Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. J. Biochem. Mol. Biol. 2006. 39: 626-635.
62. Rice, G. C., Brown, P. A., Nelson, R. J., Bianco, J. A., Singer, J. W. and Bursten, S., Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc. Natl. Acad. Sci. USA 1994. 91: 3857-3861.
63. Topham, M. K., Signaling roles of diacylglycerol kinases. J. Cell. Biochem. 2006. 97: 474-484.
64. Fukao, T. and Koyasu, S., PI3K and negative regulation of TLR signaling. Trends Immunol. 2003. 24: 358-363.
65. Yu, Y., Nagai, S., Wu, H., Neish, A. S., Koyasu, S. and Gewirtz, A. T., TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression. J. Immunol. 2006. 176: 6194-6201.
66. Venkataraman, C., Shankar, G., Sen, G. and Bondada, S., Bacterial lipopolysaccharide induced B cell activation is mediated via a phosphatidylinositol 3-kinase dependent signaling pathway. Immunol. Lett. 1999. 69: 233-238.
67. Brunn, G. J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence, J. C., Jr. and Abraham, R. T., Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 1996. 15: 5256-5267.
68. Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., Loewith, R. et al., A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 2006. 125: 733-747.
69. Fruman, D. A., Satterthwaite, A. B. and Witte, O. N., Xid-like phenotypes: A B cell signalosome takes shape. Immunity 2000. 13: 1-3.